A Blood Test That Screens 50+ Cancers Moves Closer
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
A recession-friendly withdrawal plan prioritizes sustainability. Find rules and examples to keep your withdrawals aligned with market conditions.
21,577 articlesA breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
High earners are pursuing a legal workaround—backdoor roth 401(K) conversions—to move after-tax 401(K) money into Rot...
As 2025 winds down, Coca-Cola and Exxon Mobil stand as twin blue chips with very different stories. One fuels steady ...
If Rivian hits the sweet spot with the R2, the stock story could change in meaningful ways. This guide breaks down wh...
As market volatility lingers in 2026, the timing of Social Security claims tied to birthdays can dramatically alter m...
A veteran journalist outlines Elliott Investment Management’s influence on Norwegian Cruise Line amid a strong cruise...
Meta just made striking moves in AI infrastructure that could tilt demand in Nvidia's favor. This deep dive explains ...
As memory prices surge in 2026, Corsair Gaming emerges as the leading beneficiary with improved margins, a new buybac...
A sweeping shift in capital gains rules could touch every investor. This guide breaks down what changes mean, who’s a...
A little-known rival to SCHD has delivered competitive long-run gains and steady monthly income, thanks to a mid-cap ...